Form 8-K

8-K — JBS N.V.

Accession: 0001213900-26-087444

Filed: 2026-08-11

Period: 2026-08-10

CIK: 0001791942

SIC: 2011 (MEAT PACKING PLANTS)

Item: Results of Operations and Financial Condition

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — ea0301374-8k_jbs.htm (Primary)

EX-99.1 — EARNINGS RELEASE ANNOUNCING JBS N.V.'S RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 (ea030137401ex99-1.htm)

EX-99.2 — PRESS RELEASE ISSUED BY JBS N.V. ON AUGUST 10, 2026 (ea030137401ex99-2.htm)

GRAPHIC (ea030137401_ex99-1img1.jpg)

GRAPHIC (ea030137401_ex99-1img2.jpg)

GRAPHIC (ea030137401_ex99-1img3.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0301374-8k_jbs.htm · Sequence: 1

false

0001791942

2026-08-10

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM

8-K

CURRENT REPORT

Pursuant

to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date

of Report (Date of earliest event reported): August 10, 2026

JBS

N.V.

(Exact name of registrant as specified in its charter)

Netherlands

001-42678

98-1861274

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS

Employer

Identification No.)

Stroombaan 16, 5th Floor

Amstelveen, Netherlands

1181

(Address

of principal executive offices)

(Zip Code)

+31

20 656 47 00

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is

intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General

Instruction A.2):

☐

Written communications

pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant

to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications

pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications

pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each

class

Trading Symbol(s)

Name of each

exchange on which registered

Class A common shares, par value €0.01 per share

JBS

New York Stock Exchange

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period

for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

2.02. Results of Operations and Financial Condition.

On August 10, 2026, JBS N.V. (the “Company”)

issued an earnings release announcing its results for the quarter ended June 30, 2026. A copy of the earnings release is attached hereto,

furnished as Exhibit 99.1 hereto and incorporated in this Item 2.02 by reference.

Item

5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of

Certain Officers.

August 10, 2026, the Company announced that Mr. Wesley Batista Filho, 34, will become Global CEO of the Company, effective January 2027,

as part of a planned leadership transition. Mr. Batista Filho began his career at JBS 15 years ago and has held leadership roles across

the Company's global operations, including as CEO of JBS Brazil, President of Seara and, since 2023, CEO of JBS USA. Mr. Batista Filho

is the son of Mr. Wesley Mendonça Batista and the nephew of Mr. Joesley Mendonça Batista, each of whom is a non-executive

director of the Company and together are the Company’s ultimate controlling shareholders. There are no arrangements or understandings

between Mr. Batista Filho and any other person pursuant to which he was appointed as an officer of the Company, and there are no related

party transactions involving Mr. Batista Filho that require disclosure pursuant to Item 404(a) of Regulation S-K. Mr. Batista Filho will

be paid an annual base salary and will be eligible to receive annual cash bonuses, annual equity-based grants pursuant to the Company’s

long-term incentive plan and participate in the Company’s other benefit plans.

Concurrently,

the Company announced that Mr. Gilberto Tomazoni, 67, will step down as Global CEO beginning in January 2027 after 14 distinguished years

with the Company, including eight years as Global CEO. Mr. Tomazoni will oversee the leadership transition over the next five months

before assuming the role of Vice Chairman of the Board of Directors of the Company and Senior Advisor. He will also continue to serve

as Chairman of the Board of Directors of the Company’s subsidiary Pilgrim’s Pride Corporation (PPC) and will become Chairman

of the J&F Institute, an institution dedicated to developing the next generation of business leaders. Mr. Tomazoni’s transition

is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

Item

7.01. Regulation FD Disclosure.

August 10, 2026, the Company issued a press release announcing the leadership transition described in Item 5.02 above. A copy of the

press release is furnished as Exhibit 99.2 hereto and is incorporated in this Item 7.01 by reference.

The

information contained in Items 2.02 and 7.01, and the accompanying Exhibits 99.1 and 99.2, shall not be deemed “filed” for

purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the

liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), nor

shall such information be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, regardless of

the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

Item

9.01. Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit

No.

Description

99.1

Earnings release announcing JBS N.V.’s results for the quarter ended June 30, 2026.

99.2

Press release issued by JBS N.V. on August 10, 2026.

104

Cover

Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).

SIGNATURES

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized.

Date:

August 10, 2026

JBS

N.V.

/s/

Gilberto Tomazoni

Name:

Gilberto Tomazoni

Title:

Executive Director and Global Chief Executive Officer

/s/

Guilherme Perboyre Cavalcanti

Name:

Guilherme Perboyre Cavalcanti

Title:

Global Chief Financial Officer and Investor Relations Officer

EX-99.1 — EARNINGS RELEASE ANNOUNCING JBS N.V.'S RESULTS FOR THE QUARTER ENDED JUNE 30, 2026

EX-99.1

Filename: ea030137401ex99-1.htm · Sequence: 2

Exhibit 99.1

JBS

REPORTS SECOND QUARTER 2026 RESULTS

August

10, 2026 – JBS N.V. (NYSE: JBS; B3: JBSS32), announces today its 2Q26 results. The numbers reported herein are in US dollars,

in accordance with International Financial Reporting Standards (IFRS), unless otherwise specified.

(in

millions, except per share data)

Second Quarter

Six Months Ended

2026

2025

2Q26

2Q25

Net Sales

$ 23,900

$ 20,998

$ 45,508

$ 40,524

Adjusted EBITDA (IFRS)¹ ²

$ 1,429

$ 1,754

$ 2,563

$ 3,281

Adjusted EBITDA (USGAAP)¹ ³

$ 1,257

$ 1,368

$ 2,173

$ 2,681

Adjusted Operating Income (IFRS)¹ ²

$ 790

$ 1,188

$ 1,306

$ 2,181

Adjusted Operating Income (USGAAP)¹ ³

$ 866

$ 1,034

$ 1,410

$ 2,033

Net Income Attributable to JBS²

$ -102

$ 528

$ 118

$ 1,028

Earnings Per Share Attributable to JBS²

$ -0.10

$ 0.48

$ 0.11

$ 0.93

Adjusted Earnings Per Share Attributable to JBS¹ ²

$ 0.20

$ 0.52

$ 0.43

$ 1.03

Twelve Months Ended

2Q26

2Q25

Leverage (Net Debt / Adjusted EBITDA LTM)¹ ²

3.10 x

2.27 x

Interest Coverage (Adjusted EBITDA LTM / Net Interest Expenses LTM)¹ ²

5.00 x

7.74 x

ROE LTM ¹ ²

13.4 %

25.7 %

ROIC LTM ¹ ²

13.4 %

17.0 %

(1) Reconciliations

for non-GAAP measures are provided in subsequent sections within this release.

(2) IFRS

(3) USGAAP

(non-audited)

Second

Quarter Highlights

● Net

Sales of $23.9 billion, up 14% from prior year

● IFRS

Adjusted EBITDA of $1,429 million, down 18% from prior year

● USGAAP¹

Adjusted EBITDA of $1,257 million, down 8% from prior year

● IFRS

Adjusted operating income of $790 million, down 34% from prior year

● USGAAP¹

Adjusted operating income of $866 million, down 16% from prior year

● EPS

of -$0.10, vs. $0.48 from prior year

● Adjusted

EPS of $0.20, vs. $0.52 from prior year

“In

2Q26, JBS once again reported a record revenue, reflecting the strength of the Company’s multi-geography and multi-protein platform.

Compared to last year, profitability was pressured by a tough comparison base, as the poultry operations had posted record results in

2Q25. Compared to the first quarter, profitability already showed an improvement in the majority of our business units.

The

quarter recorded a net loss of $102 million, while adjusted net income totaled $218 million, translating into adjusted EPS of $0.20.

The main non-recurring items adjusted in net income were: (i) $172 million in premiums, interest, and costs associated with the tender

offers for the bond and the CRA (Brazilian local debenture); (ii) antitrust settlements of $133 million; and (iii) the final calculation

of the bargain purchase price gain on the acquisition of Mantiqueira Alimentos, totaling $81 million; among others.

Leverage

ended 2Q26 at 3.1x, slightly above the Company’s long-term target. We also joined the Russell 1000 and Russell 3000 indices, an important

milestone that contributes to stock liquidity, expands our shareholder base, and enhances our global visibility. During the quarter,

we returned value to our shareholders through a $1 billion dividend payment.” said Gilberto Tomazoni — Global CEO.

JBS

Beef North America reported record sales in the second quarter while cutout values remained at historically high levels, supported

by resilient U.S. consumer demand. The increase in live cattle prices outpaced the change in cutout values, reflecting the low cattle

availability. As a result, industry spreads remained pressured. Live cattle imports from Mexico remained restricted during the quarter,

further constraining supply in the U.S. market, but are expected to resume gradually beginning on August 24th. In this scenario,

the Company announced the closure of two plants, one located in Souderton, Pennsylvania (processing), and the another in Memphis, Tennessee

(case ready). Production will be absorbed by other US plants, therefore with minimal impact on sales. JBS also merged the Fed Beef, Regional

Beef, and Case Ready business units into a single structure, Beef USA. These measures simplify operations, aiming at greater operational

efficiency.

Pilgrim’s

Pride saw firm chicken demand across all regions. In the U.S., Fresh volumes rose on stronger retail and foodservice demand. Profitability

declined year-over-year due to lower commodity pricing, though margins improved sequentially on productivity gains, plant upgrades, and

better live operations. Case Ready and Small Bird volumes grew via distribution with key customers. Prepared Foods delivered profitable

growth, with both sales and margins rising. In Europe, retail volumes to key customers grew faster than the overall grocery channel,

helping offset pressured pork margins from higher UK imports, added costs from the Middle East conflict, and softer foodservice traffic.

In Mexico, volumes rose across fresh and prepared products. Chicken demand stayed robust despite a significant rise in overall protein

supply. Across key markets, growth in branded and prepared offerings, along with ongoing investments, will further mitigate commodity

market challenges and strengthen margins while reducing risk.

JBS

USA Pork reported flat revenue compared to the prior year. Domestic demand for pork softened as inflation pressured the American

consumer. According to the USDA, pork exports continued to stay above last year’s level and were up 4.7% Y/Y during January through

May. The Company continues to invest in expanding its value-added and branded product portfolio. JBS USA Pork, the Company’s most resilient

business unit, maintained its profitability within its historical range.

JBS

Australia net sales growth in 2Q26 was driven by higher prices and volumes. The beef segment delivered strong revenue growth, supported

by higher prices in both domestic and export markets. Strong commercial dynamics, combined with continued operational efficiency gains,

more than offset the 24% year-over-year increase in cattle costs in 2Q26. Pork profitability was also a highlight, driven by operational

execution and higher productivity. The weaker U.S. dollar relative to the Australian dollar continued to weigh on the translation of

results into U.S. dollars versus the prior-year period.

JBS

Brazil also reported record sales for a second quarter. The revenue growth reflects higher prices and volumes in both the export

and domestic markets. In the export market, strong revenue growth was driven by higher prices and volumes, mainly to fill the Chinese

quota. Robust global demand and the Company’s geographic diversification strategy also boosted exports. In the domestic market, higher

prices and volumes for beef were driven by World Cup-related marketing initiatives and stronger commercial execution, particularly through

partnerships with key customers. In relation to costs, the average live cattle price during the quarter was approximately R$353/@, an

increase of 12% compared to 2Q25. Even with elevated cattle prices, JBS reported its highest EBITDA for a second quarter.

Seara

reported an 18% sales growth compared to the same period of last year, with a strong adjusted EBITDA margin of 14.9% in 2Q26. In the

export market, the Company maintained its sales growth driven by higher volumes of fresh poultry. Another highlight was the sales to

the Middle East, despite a more challenging operating environment resulting from the conflict. Investments Seara has been making in the

region supported volume growth, especially for value-added and branded products. In the Brazilian market, Seara continued to invest in

its fundamentals, expanding its value-added portfolio, increasing processing capacity for fresh and prepared products, strengthening

its brand, and maintaining solid commercial and operational execution. As a result, the Company delivered a strong performance, reinforcing

the consistency of its strategy and operational discipline.

Free

Cash Flow & Leverage

Free

cash flow in 2Q26 improved by US$185 million year-over-year, reaching a positive US$130 million, compared to a cash consumption of US$55

million in 2Q25. The improvement was mainly driven by working capital, particularly (i) a US$600 million improvement in receivables,

reflecting higher receivables discounting and larger advance payments from Chinese customers related to JBS Brazil’s exports, and (ii)

a US$390 million increase in payables, driven mainly by higher cattle prices and increased slaughter volumes, particularly in Brazil.

These effects were partially offset by (i) a US$324 million decline in Adjusted EBITDA, (ii) a US$129 million increase in net cash interest

expenses and (iii) a US$163 million increase in capex.

The

average debt term reached 15.3 years, with an average cost of 5.7%. Net leverage ended the quarter at 3.1x, slightly above the company’s

long-term financial target. In August, JBS increased its revolving credit facility from US$3.5 billion to US$4.2 billion, while reducing

the all-in cost. Considering this increase, JBS grew its total liquidity to US$7.7 billion.

SEGMENT

RESULTS

JBS Beef North America

Second Quarter

Six Months Ended

IFRS - US$ Million

2026

2025

Var %

2Q26

2Q25

Var %

Net Sales

$ 7,770

$ 6,805

14.2 %

$ 14,936

$ 13,227

12.9 %

Cost of Sales

$ (7,661 )

$ (6,826 )

12.2 %

$ (14,890 )

$ (13,149 )

13.2 %

Gross Profit

$ 109

$ (21 )

$ 46

$ 77

-39.9 %

Adjusted EBITDA

$ (78 )

$ (233 )

-66.4 %

$ (345 )

$ (333 )

3.5 %

Margin (%)

-1.0 %

-3.4 %

2.4 p.p.

-2.3 %

-2.5 %

0.2 p.p.

Adjusted Operating Income

$ (138 )

$ (293 )

-52.9 %

$ (467 )

$ (451 )

3.5 %

Margin (%)

-1.8 %

-4.3 %

2.5 p.p.

-3.1 %

-3.4 %

0.3 p.p.

Second Quarter

Six Months Ended

USGAAP¹ - US$ Million

2026

2025

Var %

2Q26

2Q25

Var %

Net Sales

$ 7,770

$ 6,805

14.2 %

$ 14,936

$ 13,227

12.9 %

Cost of Sales

$ (7,846 )

$ (7,040 )

11.5 %

$ (15,209 )

$ (13,552 )

12.2 %

Gross Profit

$ (76 )

$ (235 )

-67.5 %

$ (273 )

$ (325 )

-16.0 %

Adjusted EBITDA

$ (100 )

$ (264 )

-62.1 %

$ (330 )

$ (377 )

-12.5 %

Margin (%)

-1.3 %

-3.9 %

2.6 p.p.

-2.2 %

-2.9 %

0.7 p.p.

Adjusted Operating Income

$ (148 )

$ (312 )

-52.7 %

$ (427 )

$ (471 )

-9.2 %

Margin (%)

-1.9 %

-4.6 %

2.7 p.p.

-2.9 %

-3.6 %

0.7 p.p.

Pilgrim’s Pride

Second Quarter

Six Months Ended

IFRS - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 4,623

$ 4,755

-2.8 %

$ 9,153

$ 9,214

-0.7 %

Cost of Sales

$ (4,003 )

$ (3,811 )

5.0 %

$ (7,918 )

$ (7,482 )

5.8 %

Gross Profit

$ 620

$ 944

-34.3 %

$ 1,234

$ 1,732

-28.7 %

Adjusted EBITDA

$ 503

$ 818

-38.5 %

$ 953

$ 1,478

-35.5 %

Margin (%)

10.9 %

17.2 %

-6.3 p.p.

10.4 %

16.0 %

-5.6 p.p.

Adjusted Operating Income

$ 240

$ 576

-58.4 %

$ 432

$ 1,006

-57.0 %

Margin (%)

5.2 %

12.1 %

-6.9 p.p.

4.7 %

10.9 %

-6.2 p.p.

Second Quarter

Six Months Ended

USGAAP¹ - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 4,626

$ 4,757

-2.8 %

$ 9,159

$ 9,220

-0.7 %

Cost of Sales

$ (4,286 )

$ (4,042 )

6.0 %

$ (8,474 )

$ (7,950 )

6.6 %

Gross Profit

$ 340

$ 715

-52.5 %

$ 685

$ 1,270

-46.1 %

Adjusted EBITDA

$ 360

$ 687

-47.6 %

$ 668

$ 1,220

-45.2 %

Margin (%)

7.8 %

14.4 %

-6.6 p.p.

7.3 %

13.2 %

-5.9 p.p.

Adjusted Operating Income

$ 237

$ 573

-58.7 %

$ 426

$ 1,002

-57.5 %

Margin (%)

5.1 %

12.1 %

-7.0 p.p.

4.7 %

10.9 %

-6.2 p.p.

JBS Brazil

Second Quarter

Six Months Ended

IFRS - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 4,585

$ 3,581

28.0 %

$ 8,373

$ 6,751

24.0 %

Cost of Sales

$ (3,959 )

$ (3,032 )

30.6 %

$ (7,232 )

$ (5,733 )

26.1 %

Gross Profit

$ 625

$ 549

14.0 %

$ 1,142

$ 1,018

12.2 %

Adjusted EBITDA

$ 269

$ 229

17.8 %

$ 437

$ 360

21.5 %

Margin (%)

5.9 %

6.4 %

-0.5 p.p.

5.2 %

5.3 %

-0.1 p.p.

Adjusted Operating Income

$ 195

$ 174

12.5 %

$ 297

$ 253

17.1 %

Margin (%)

4.3 %

4.8 %

-0.5 p.p.

3.5 %

3.8 %

-0.3 p.p.

Second Quarter

Six Months Ended

USGAAP¹ - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 4,585

$ 3,581

28.0 %

$ 8,373

$ 6,751

24.0 %

Cost of Sales

$ (4,158 )

$ (3,198 )

30.0 %

$ (7,606 )

$ (6,055 )

25.6 %

Gross Profit

$ 426

$ 383

11.3 %

$ 767

$ 696

10.2 %

Adjusted EBITDA

$ 273

$ 223

22.1 %

$ 445

$ 349

27.6 %

Margin (%)

5.9 %

6.2 %

-0.3 p.p.

5.3 %

5.2 %

0.1 p.p.

Adjusted Operating Income

$ 200

$ 171

16.3 %

$ 306

$ 249

22.8 %

Margin (%)

4.4 %

4.8 %

-0.4 p.p.

3.7 %

0.0 p.p.

(1) USGAAP

(non-audited)

Seara

Second Quarter

Six Months Ended

IFRS - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 2,560

$ 2,166

18.2 %

$ 4,940

$ 4,317

14.4 %

Cost of Sales

$ (1,949 )

$ (1,593 )

22.3 %

$ (3,747 )

$ (3,115 )

20.3 %

Gross Profit

$ 612

$ 573

6.8 %

$ 1,193

$ 1,202

-0.8 %

Adjusted EBITDA

$ 380

$ 392

-2.9 %

$ 750

$ 817

-8.3 %

Margin (%)

14.9 %

18.1 %

-3.2 p.p.

15.2 %

18.9 %

-3.7 p.p.

Adjusted Operating Income

$ 252

$ 293

-14.1 %

$ 500

$ 630

-20.6 %

Margin (%)

9.8 %

13.5 %

-3.7 p.p.

10.1 %

14.6 %

-4.5 p.p.

Second Quarter

Six Months Ended

USGAAP¹ - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 2,560

$ 2,166

18.2 %

$ 4,940

$ 4,317

14.4 %

Cost of Sales

$ (2,129 )

$ (1,684 )

26.4 %

$ (4,093 )

$ (3,307 )

23.8 %

Gross Profit

$ 431

$ 482

-10.6 %

$ 846

$ 1,010

-16.2 %

Adjusted EBITDA

$ 315

$ 334

-5.8 %

$ 619

$ 706

-12.3 %

Margin (%)

12.3 %

15.4 %

-3.1 p.p.

12.5 %

16.4 %

-3.9 p.p.

Adjusted Operating Income

$ 250

$ 290

-13.9 %

$ 496

$ 621

-20.2 %

Margin (%)

9.7 %

13.4 %

-3.7 p.p.

10.0 %

14.4 %

-4.4 p.p.

JBS Australia

Second Quarter

Six Months Ended

IFRS - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 2,565

$ 1,973

30.0 %

$ 4,710

$ 3,594

31.0 %

Cost of Sales

$ (2,232 )

$ (1,571 )

42.0 %

$ (4,133 )

$ (2,942 )

40.4 %

Gross Profit

$ 334

$ 401

-16.9 %

$ 578

$ 652

-11.4 %

Adjusted EBITDA

$ 231

$ 290

-20.5 %

$ 363

$ 451

-19.3 %

Margin (%)

9.0 %

14.7 %

-5.7 p.p.

7.7 %

12.5 %

-4.8 p.p.

Adjusted Operating Income

$ 195

$ 260

-24.9 %

$ 294

$ 391

-24.7 %

Margin (%)

7.6 %

13.2 %

-5.6 p.p.

6.2 %

10.9 %

-4.7 p.p.

Second Quarter

Six Months Ended

USGAAP¹ - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 2,565

$ 1,973

30.0 %

$ 4,710

$ 3,594

31.0 %

Cost of Sales

$ (2,317 )

$ (1,689 )

37.2 %

$ (4,288 )

$ (3,121 )

37.4 %

Gross Profit

$ 249

$ 284

-12.3 %

$ 423

$ 473

-10.7 %

Adjusted EBITDA

$ 218

$ 251

-12.8 %

$ 370

$ 419

-11.7 %

Margin (%)

8.5 %

12.7 %

-4.2 p.p.

7.9 %

11.7 %

-3.8 p.p.

Adjusted Operating Income

$ 195

$ 231

-15.8 %

$ 324

$ 380

-14.8 %

Margin (%)

7.6 %

11.7 %

-4.1 p.p.

6.9 %

10.6 %

-3.7 p.p.

JBS USA Pork

Second Quarter

Six Months Ended

IFRS - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 2,079

$ 2,059

1.0 %

$ 4,111

$ 4,061

1.2 %

Cost of Sales

$ (1,826 )

$ (1,700 )

7.4 %

$ (3,457 )

$ (3,334 )

3.7 %

Gross Profit

$ 254

$ 359

-29.4 %

$ 654

$ 727

-10.1 %

Adjusted EBITDA

$ 117

$ 254

-54.0 %

$ 391

$ 501

-22.0 %

Margin (%)

5.6 %

12.3 %

-6.7 p.p.

9.5 %

12.3 %

-2.8 p.p.

Adjusted Operating Income

$ 49

$ 185

-73.2 %

$ 257

$ 364

-29.4 %

Margin (%)

2.4 %

9.0 %

-6.6 p.p.

6.2 %

9.0 %

-2.8 p.p.

Second Quarter

Six Months Ended

USGAAP¹ - US$ Million

2026

2025

Var %

2026

2025

Var %

Net Sales

$ 2,079

$ 2,059

1.0 %

$ 4,111

$ 4,061

1.2 %

Cost of Sales

$ (1,883 )

$ (1,916 )

-1.7 %

$ (3,700 )

$ (3,687 )

0.3 %

Gross Profit

$ 196

$ 143

37.6 %

$ 411

$ 373

10.2 %

Adjusted EBITDA

$ 184

$ 134

38.0 %

$ 388

$ 356

8.9 %

Margin (%)

8.9 %

6.5 %

2.4 p.p.

9.4 %

8.8 %

0.6 p.p.

Adjusted Operating Income

$ 136

$ 87

56.3 %

$ 292

$ 264

10.7 %

Margin (%)

6.6 %

4.2 %

2.4 p.p.

7.1 %

6.5 %

0.6 p.p.

(1) USGAAP

(non-audited)

CONSOLIDATED

CONDENSED STATEMENTS OF INCOME

(In

millions, except per share data)

(Unaudited)

Second Quarter

Six Months Ended

2026

2025

2026

2025

Net Sales

$ 23,899.6

$ 20,997.7

$ 45,508.2

$ 40,524.2

Cost of Sales

(21,311.7 )

(18,165.1 )

(40,595.7 )

(35,067.1 )

Gross Profit

2,587.9

2,832.5

4,912.5

5,457.1

Selling expenses

(1,411.0 )

(1,207.0 )

(2,713.5 )

(2,394.6 )

General and administrative expenses

(588.1 )

(522.3 )

(1,143.7 )

(1,078.7 )

Other income(expenses)

8.3

1.9

26.4

4.3

Net Operating Expenses

(1,990.8 )

(1,727.4 )

(3,830.9 )

(3,469.1 )

Operating Income

597.1

1,105.1

1,081.6

1,988.0

Finance Income

135.7

69.4

307.8

305.1

Finance Expense

(831.2 )

(445.8 )

(1,317.6 )

(873.0 )

Net Finance Expense

(695.6 )

(376.4 )

(1,009.8 )

(568.0 )

Share of profit of equity-accounted investees, net of tax

(123.6 )

7.8

14.8

10.6

Profit (Loss) Before Taxes

(222.1 )

736.5

86.6

1,430.6

Current Income Taxes

(18.1 )

(165.7 )

(51.9 )

(390.5 )

Deferred Income Taxes

144.0

23.5

110.7

110.5

Total Income Taxes

125.9

(142.2 )

58.8

(280.0 )

Effective Rate

(56.7 )%

(19.3 )%

67.9 %

(19.6 )%

Net Income (Loss)

(96.2 )

594.3

145.4

1,150.6

Attributable to:

Company shareholders

(102.1 )

528.1

118.5

1,028.3

Non-controlling interest

5.9

66.2

26.9

122.3

Earnings per Share (US$)

$ (0.10 )

$ 0.48

$ 0.11

$ 0.93

Second Quarter

Six Months Ended

IFRS - US$ Million

2026

2025

Var %

2026

2025

Var %

Adjusted EBITDA

$ 1,429.3

$ 1,753.6

-18.5 %

$ 2,562.7

$ 3,281.4

-21.9 %

Margin (%)

6.0 %

8.4 %

-2.4 p.p.

5.6 %

8.1 %

-2.5 p.p.

Adjusted Operating Income

$ 790.2

$ 1,188.4

-33.5 %

$ 1,306.1

$ 2,180.5

-40.1 %

Margin (%)

3.3 %

5.7 %

-2.4 p.p.

2.9 %

5.4 %

-2.5 p.p.

Second Quarter

Six Months Ended

USGAAP¹ - US$ Million

2026

2025

Var %

2026

2025

Var %

Adjusted EBITDA

$ 1,256.6

$ 1,368.3

-8.2 %

$ 2,173.1

$ 2,680.7

-18.9 %

Margin (%)

5.3 %

6.5 %

-1.2 p.p.

4.8 %

6.6 %

-1.8 p.p.

Adjusted Operating Income

$ 865.9

$ 1,034.2

-16.3 %

$ 1,409.8

$ 2,032.8

-30.6 %

Margin (%)

3.6 %

4.9 %

-1.3 p.p.

3.1 %

5.0 %

-1.9 p.p.

(1) USGAAP

(non-audited)

CONSOLIDATED

CONDENSED BALANCE SHEETS

(In

millions)

(Unaudited)

June 30,

2026

December 31,

2025

Assets

Current Assets:

Cash and cash equivalents

$ 3,469.1

$ 4,565.1

Margin Cash

168.3

159.6

Trade accounts receivable

3,555.4

4,231.9

Inventories

6,996.2

6,107.2

Biological assets

1,810.3

1,826.8

Recoverable taxes

1,088.9

957.2

Derivative assets

118.2

155.6

Dividends receivable

1.5

Other current assets

550.4

433.4

Total Current Assets

17,756.8

18,438.2

Non Current Assets:

Long-term Investments

50.9

45.8

Recoverable taxes

2,085.7

1,874.6

Biological assets

660.1

611.8

Related party receivables

32.7

41.2

Deferred income taxes

656.1

547.0

Other non-current assets

563.9

488.8

4,049.4

3,609.2

Investments in equity-accounted investees

225.7

171.6

Property, plant and equipment

14,416.0

13,645.7

Right of use assets

1,621.8

1,613.6

Intangible assets

1,784.8

1,825.6

Goodwill

5,983.9

5,852.6

Total Non Current Assets

28,081.6

26,718.3

Total Assets

$ 45,838.4

$ 45,156.5

June 30,

2026

December 31,

2025

Liabilities and Equity

Current Liabilities:

Trade accounts payable

$ 5,851.7

$ 6,198.1

Supply chain finance

1,195.5

1,134.5

Loans and financing

1,334.9

833.1

Income taxes

122.9

288.0

Other taxes payable

187.6

153.0

Payroll and social charges

1,378.3

1,560.2

Lease liabilities

368.7

354.9

Dividends payable

0.1

Provisions for legal proceedings

220.4

159.2

Derivative liabilities

116.8

156.4

Other current liabilities

805.6

704.5

Total Current Liabilities

11,582.6

11,541.8

Non Current Liabilities:

Loans and financings

21,315.8

20,257.5

Income and other taxes payable

424.4

407.7

Payroll and social charges

337.8

288.1

Lease liabilities

1,425.5

1,412.4

Deferred income taxes

1,175.1

1,169.3

Provisions for legal proceedings

223.5

209.4

Related party payable

142.5

191.0

Derivative liabilities

101.9

114.4

Other non-current liabilities

50.1

42.2

Total Non Current Liabilities

25,196.7

24,091.9

Equity:

Share capital - common shares

41.6

35.1

Reserves

8,064.3

6,582.7

Undistributed results

118.5

2,085.8

Attributable to company shareholders

8,224.3

8,703.6

Attributable to non-controlling interest

834.8

819.2

Total Equity

9,059.1

9,522.8

Total Liabilities and Equity

$ 45,838.4

$ 45,156.5

CONSOLIDATED

CONDENSED STATEMENTS OF CASH FLOWS

(In

millions)

(Unaudited)

Second Quarter

Six Months Ended

2026

2025

2026

2025

Net income

$ (96.2 )

$ 594.3

145.4

1,150.6

Adjustments for:

Depreciation and amortization

639.1

565.2

1,256.6

1,100.8

Expected credit losses

2.3

0.4

5.0

13.3

Share of profit of equity-accounted investees

123.6

(7.8 )

(14.8 )

(10.6 )

(Gain) loss on assets sales

(0.5 )

1.9

(13.3 )

(8.9 )

Taxes expense

(125.9 )

142.2

(58.8 )

280.0

Net finance expense

695.6

376.4

1,009.8

568.0

Share-based compensation

19.7

7.1

25.8

14.1

Provisions for legal procedings

48.2

1.5

73.0

15.6

Impairment of goodwill and property, plant and equipment

22.6

7.4

22.6

13.6

Net realizable value inventory adjustments

16.2

3.3

32.0

20.4

Fair value adjustment of biological assets

96.3

(95.7 )

71.5

(86.5 )

Avian Influenza

5.6

DOJ (Department of Justice) and antitrust agreements

132.7

54.1

157.4

133.6

1,573.7

1,655.9

2,712.2

3,209.7

Changes in assets and liabilities:

Trade accounts receivable

352.5

(76.8 )

683.6

160.1

Inventories

(242.2 )

(314.3 )

(824.6 )

(955.2 )

Recoverable taxes

(22.1 )

51.7

(19.5 )

93.8

Other current and non-current assets

(96.1 )

(73.6 )

(88.2 )

(362.2 )

Biological assets

(232.8 )

(206.8 )

(415.8 )

(398.1 )

Trade accounts payable and supply chain finance

361.6

(28.0 )

(437.7 )

(575.4 )

Taxes paid in installments

(8.7 )

(44.9 )

(23.0 )

(51.9 )

Other current and non-current liabilities

(115.8 )

247.9

(294.1 )

179.4

DOJ and Antitrust agreements payment

(146.1 )

(121.5 )

(98.8 )

(261.2 )

Income taxes paid

(181.8 )

(316.6 )

(400.3 )

(550.9 )

Changes in operating assets and liabilities

(331.5 )

(883.0 )

(1,918.5 )

(2,721.6 )

Cash provided by operating activities

1,242.2

772.9

793.7

488.1

Interest paid

(444.0 )

(293.4 )

(810.8 )

(604.9 )

Interest received

53.8

31.9

79.9

73.7

Cash net of interest provided by (used in) operating activities

852.1

511.4

62.8

(43.1 )

Cash flow from investing activities:

Purchases of property, plant and equipment

(612.5 )

(449.5 )

(1,178.9 )

(714.1 )

Purchases and disposals of intangible assets

(2.2 )

0.1

(7.2 )

(2.6 )

Proceeds from sale of property, plant and equipment

19.5

13.8

48.1

35.6

Additional/Acquistion investments in equity-accounted investees

(0.0 )

(165.3 )

26.4

(165.3 )

Dividends received

0.2

2.2

0.2

4.1

Related party transactions

(18.5 )

4.6

(16.8 )

4.6

Cash provided by (used in) investing activities

(613.5 )

(594.0 )

(1,128.2 )

(837.6 )

Cash flow from financing activities:

Proceeds from loans and financings

3,332.5

2,313.2

3,865.5

4,494.2

Payments of loans and financings

(2,265.8 )

(2,925.7 )

(2,700.7 )

(4,676.4 )

Derivative instruments received (settled)

13.7

(44.0 )

(6.5 )

(52.9 )

Dividends paid

(1,039.1 )

(1,194.3 )

(1,039.1 )

(1,573.9 )

Dividends paid to non-controlling interest

(1.1 )

(265.5 )

(2.9 )

(266.4 )

Margin Cash

(4.0 )

(66.6 )

(35.4 )

(44.4 )

Payments of leasing contracts

(109.8 )

(116.8 )

(220.8 )

(215.1 )

Acquisition of treasury shares

1.2

Others

(2.8 )

Cash provided by (used in) financing activities

(73.7 )

(2,299.8 )

(141.4 )

(2,334.8 )

Effect of exchange rate changes on cash and cash equivalents

9.4

75.2

110.8

120.5

Net change in cash and cash equivalents

174.3

(2,307.2 )

(1,096.0 )

(3,094.9 )

Cash and cash equivalents at the beggining of period

3,294.8

4,826.0

4,565.1

5,613.7

Cash and cash equivalents at the end of period

$ 3,469.1

$ 2,518.8

$ 3,469.1

$ 2,518.8

Adjusted

EBITDA IFRS to USGAAP Reconciliations

(In

millions)

(Unaudited)

Adjusted EBITDA

2Q26

JBS Beef North America

PPC

JBS Brazil

Seara

JBS

USA Pork

Australia

Miscellaneous

Total

Adjusted EBITDA IFRS

$ (78.3 )

$ 502.9

$ 269.2

$ 380.4

$ 116.7

$ 230.7

$ 7.6

$ 1,429.3

Leasing adjustments

(14.4 )

(20.5 )

(2.9 )

(10.8 )

(22.4 )

(14.4 )

(0.5 )

(85.9 )

Inventory adjustments at market value

(7.4 )

(11.1 )

(18.6 )

Biological assets adjustments

(123.1 )

6.4

(55.1 )

101.1

2.1

(68.6 )

Other adjustments

(0.1 )

0.7

(0.3 )

0.3

Adjusted EBITDA USGAAP¹

$ (100.3 )

$ 360.0

$ 272.8

$ 314.5

$ 184.3

$ 218.5

$ 6.8

$ 1,256.6

Adjusted EBITDA

2Q25

JBS Beef North America

PPC

JBS Brazil

Seara

JBS

USA Pork

Australia

Miscellaneous

Total

Adjusted EBITDA IFRS

$ (233.0 )

$ 817.7

$ 228.6

$ 391.8

$ 253.6

$ 290.2

$ 4.7

$ 1,753.6

Leasing adjustments

(14.4 )

(19.8 )

(3.5 )

(13.8 )

(26.3 )

(13.0 )

(0.6 )

(91.4 )

Inventory adjustments at market value

(16.9 )

(29.8 )

(46.7 )

Biological assets adjustments

(111.2 )

(1.6 )

(44.2 )

(63.9 )

(26.7 )

(247.6 )

Other adjustments

(0.1 )

0.1

0.4

0.5

Adjusted EBITDA USGAAP¹

$ (264.4 )

686.9

$ 223.5

$ 333.8

$ 133.6

$ 250.5

$ 4.5

$ 1,368.3

Adjusted EBITDA

6M26

JBS Beef North America

PPC

JBS Brazil

Seara

JBS

USA Pork

Australia

Miscellaneous

Total

Adjusted EBITDA IFRS

$ (345.0 )

$ 952.6

$ 436.9

$ 749.7

$ 390.8

$ 363.5

$ 14.2

$ 2,562.7

Leasing adjustments

(29.3 )

(42.3 )

(7.0 )

(22.3 )

(44.2 )

(28.2 )

(1.0 )

(174.4 )

Inventory adjustments at market value

44.6

(10.5 )

34.0

Biological assets adjustments

(243.2 )

14.9

(108.5 )

52.0

35.1

(249.7 )

Other adjustments

(0.3 )

1.1

(0.3 )

0.5

Adjusted EBITDA USGAAP¹

$ (330.2 )

668.1

$ 444.8

$ 618.9

$ 388.1

$ 370.4

$ 12.8

$ 2,173.1

Adjusted EBITDA

6M25

JBS Beef North America

PPC

JBS Brazil

Seara

JBS

USA Pork

Australia

Miscellaneous

Total

Adjusted EBITDA IFRS

$ (333.5 )

$ 1,477.9

$ 359.7

$ 817.5

$ 500.9

$ 450.5

$ 8.3

$ 3,281.4

Leasing adjustments

(29.2 )

(39.5 )

(7.9 )

(29.5 )

(51.7 )

(25.2 )

(1.3 )

(184.4 )

Inventory adjustments at market value

(14.6 )

(23.8 )

(38.5 )

Biological assets adjustments

(218.9 )

(3.1 )

(82.1 )

(69.1 )

(6.0 )

(379.1 )

Other adjustments

(0.0 )

0.6

0.8

1.3

Adjusted EBITDA USGAAP¹

$ (377.3 )

$ 1,220.1

$ 348.6

$ 705.9

$ 356.3

$ 419.4

$ 7.7

$ 2,680.8

(1) USGAAP

(non-audited)

Adjusted

Operating Income IFRS to USGAAP Reconciliations

(In millions)

(Unaudited)

Adjusted Operating Income (Loss)

2Q26

JBS Beef North America

PPC

JBS Brazil

Seara

JBS

USA Pork

Australia

Miscellaneous

Total

Adjusted Operating Income IFRS

$ (138.1 )

$ 239.7

$ 195.3

$ 251.7

$ 49.5

$ 195.3

$ (3.2 )

$ 790.2

Leasing adjustments

(2.5 )

(3.2 )

(2.6 )

(2.1 )

(3.1 )

(2.9 )

(0.0 )

(16.5 )

Inventory adjustments at market value

(7.4 )

(11.1 )

(18.6 )

Biological assets adjustments

6.9

101.1

2.1

110.1

Other adjustments

0.2

0.6

Adjusted Operating Income USGAAP¹

$ (147.9 )

$ 236.7

$ 199.5

$ 249.6

$ 136.3

$ 194.6

$ (3.0 )

$ 865.9

Adjusted Operating Income (Loss)

2Q25

JBS Beef North America

PPC

JBS Brazil

Seara

JBS

USA Pork

Australia

Miscellaneous

Total

Adjusted Operating Income IFRS

$ (292.9 )

$ 575.8

$ 173.6

$ 293.2

$ 184.7

$ 260.1

$ (6.2 )

$ 1,188.4

Leasing adjustments

(2.6 )

(3.1 )

(0.5 )

(3.4 )

(3.8 )

(2.4 )

(0.0 )

(15.9 )

Inventory adjustments at market value

(16.9 )

(29.8 )

(46.7 )

Biological assets adjustments

(1.6 )

(63.9 )

(26.7 )

(92.3 )

Other adjustments

0.1

0.6

(0.0 )

0.7

Adjusted Operating Income USGAAP¹

$ (312.3 )

$ 573.4

$ 171.5

$ 289.8

$ 87.2

$ 230.9

$ (6.2 )

$ 1,034.2

Adjusted Operating Income (Loss)

6M26

JBS Beef North America

PPC

JBS Brazil

Seara

JBS

USA Pork

Australia

Miscellaneous

Total

Adjusted Operating Income IFRS

$ (466.9 )

$ 432.5

$ 296.6

$ 500.1

$ 256.7

$ 294.2

$ (7.1 )

$ 1,306.1

Leasing adjustments

(5.1 )

(6.5 )

(6.2 )

(4.3 )

(6.2 )

(5.5 )

(0.1 )

(33.9 )

Inventory adjustments at market value

44.6

(10.5 )

34.0

Biological assets adjustments

15.5

52.0

35.1

102.6

Other adjustments

0.2

0.3

$ 0.5

1.0

Adjusted Operating Income USGAAP¹

$ (427.2 )

$ 426.3

$ 305.9

$ 495.8

$ 292.0

$ 323.8

$ (6.7 )

$ 1,409.8

Adjusted Operating Income (Loss)

6M25

JBS Beef North America

PPC

JBS Brazil

Seara

JBS

USA Pork

Australia

Miscellaneous

Total

Adjusted Operating Income IFRS

$ (451.2 )

$ 1,006.5

$ 253.2

$ 629.8

$ 363.8

$ 390.7

$ (12.4 )

$ 2,180.5

Leasing adjustments

(5.4 )

(5.9 )

(1.0 )

(8.7 )

(7.1 )

(4.8 )

(0.0 )

(32.9 )

Inventory adjustments at market value

(14.6 )

(23.8 )

(38.5 )

Biological assets adjustments

(3.1 )

(69.1 )

(6.0 )

(78.1 )

Other adjustments

0.5

1.5

(0.2 )

1.8

Adjusted Operating Income USGAAP¹

$ (470.7 )

1,002.1

$ 249.1

$ 621.1

$ 263.8

$ 379.9

$ (12.6 )

$ 2,032.8

(1) USGAAP

(non-audited)

EBITDA

to Adjusted EBITDA and Free Cash Flow Reconciliation

(In

millions)

Second Quarter

Twelve Months Ended

2026

2025

2Q26

2Q25

Profit before Taxes

$ (222.1 )

$ 736.5

$ 1,276.3

$ 3,237.0

Share of profit of equity-accounted investees, net of tax

123.6

(7.8 )

(21.1 )

(17.6 )

Net finance results

695.6

376.4

1,998.1

1,289.4

(+) Depreciation and amortization

639.1

565.2

2,464.3

2,199.6

EBITDA

$ 1,236.2

$ 1,670.3

$ 5,717.6

$ 6,708.3

Adjustments to EBITDA:

Other operating income (expense), net

$ 9.3

$ 9.0

$ 38.4

$ 38.2

Tax Assesment Notice

43.2

Reestructuring

17.3

4.5

32.0

64.9

Impairment of assets

7.1

8.4

12.8

Antitrust agreements

132.7

54.1

206.0

307.1

Donations and Social Programs

0.6

1.2

9.0

Rio Grande do Sul claim

13.1

Fiscal payments and installments

9.6

2.4

9.6

2.4

Extemporaneous litigation

20.7

61.0

Reversal of tax credits

58.7

Avian influenza

5.6

11.5

5.6

Closure of Plants

24.1

Total Adjusted EBITDA

$ 1,429.3

$ 1,753.6

$ 6,112.7

$ 7,281.0

(-) Depreciation and amortization

639.1

565.2

2,464.3

2,199.6

Adjusted Operating Income (IFRS)

$ 790.2

$ 1,188.4

$ 3,648.5

$ 5,081.4

Total Gross Debt

22,650.7

19,491.8

22,650.7

19,491.8

(-)Cash and Equivalents

3,469.1

2,518.8

3,469.1

2,518.8

(-) Cash Margin

168.3

449.2

168.3

449.2

(-) Financial Investments

50.9

Total Net Debt

$ 18,962.3

$ 16,523.8

$ 18,962.3

$ 16,523.8

Ratio Calculations:

Gross Debt/Adjusted EBITDA

3.71 x

2.68 x

Net Debt/Adjusted EBITDA

3.10 x

2.27 x

Second Quarter

Twelve Months Ended

2026

2025

2Q26

2Q25

Cash provided by operating activities

$ 1,242.2

$ 772.9

$ 4,352.2

$ 4,147.7

Interest paid and received

(390.2 )

(261.5 )

(1,313.5 )

(1,233.7 )

Purchases of property, plant and equipment

(612.5 )

(449.5 )

(2,564.0 )

(1,564.7 )

Payments of leasing contracts

(109.8 )

(116.8 )

(438.3 )

(421.8 )

Free Cash Flow

$ 129.7

$ (54.9 )

$ 36.4

$ 927.5

Net

Debt Bridge and Proforma Debt Amortization Schedule

(In

millions)

(Unaudited)

(1) Considering

acquisitions, non-cash items and Others.

Adjusted

Net Income Reconciliation

(In

millions)

(Unaudited)

Second Quarter

Six Months Ended

2026

2025

2026

2025

Net Income (Loss)

$ (96.2 )

$ 594.3

$ 145.4

$ 1,150.6

Non-controlling interest

(5.9 )

(66.2 )

(26.9 )

(122.3 )

Net income (Loss) Attributable to JBS

$ (102.1 )

$ 528.1

$ 118.5

$ 1,028.3

Adjustments to Net Income:

Other operating income / expense

$ 9.3

$ 9.0

$ 12.7

$ 15.4

Reestructuring

17.3

4.5

20.1

21.5

Antitrust agreements

132.7

54.1

157.4

133.6

Donations and Social Programs

0.6

0.5

1.1

Avian influenza

5.6

Fiscal payments and installments

9.6

2.4

9.6

2.4

Closure of Plants

24.1

Final calculation of the bargain purchase price gain

80.5

Bond and CRA premiums

172.1

Costs Related to the War

39.8

Taxes

(165.1 )

(25.9 )

(175.7 )

(61.1 )

Adjusted Net income Attributable to JBS

$ 218.3

$ 578.4

$ 459.6

$ 1,146.9

Adjusted Earnings Per Share Attributable to JBS

$ 0.20

$ 0.52

$ 0.43

$ 1.03

ROE,

ROIC and Interest Coverage Reconciliation

(In

millions)

(Unaudited)

Last twelve months

ended June 30,

2026

2025

Net Income LTM (A)

$ 1,224.6

$ 2,365.6

Average Shareholder Equity (B)

$ 9,152.7

$ 9,190.9

Current Shareholder Equity

$ 9,059.1

$ 9,246.4

Previous Year Shareholder Equity

$ 9,246.4

$ 9,135.5

ROE (A/B)

13.4 %

25.7 %

Last twelve months

ended June 30,

2026

2025

NOPAT (A)

$ 3,596.7

$ 4,210.1

Adjusted Operating Income (IFRS)

$ 3,648.5

$ 5,081.4

Taxes

$ -51.7

$ -871.4

Average Net Debt (B)

$ 17,743.1

$ 15,641.6

Current Net Debt

$ 18,962.3

$ 16,523.8

Previous Year Net Debt

$ 16,523.8

$ 14,759.4

Average Shareholder Equity (C)

$ 9,152.7

$ 9,190.9

Current Shareholder Equity

$ 9,059.1

$ 9,246.4

Previous Year Shareholder Equity

$ 9,246.4

$ 9,135.5

Invested Capital (B+C)

$ 26,895.8

$ 24,832.6

ROIC [A/(B+C)]

13.4 %

17.0 %

Last twelve months

ended June 30,

2026

2025

Total Adjusted EBITDA

$ 6,112.7

$ 7,281.0

Net Financial Expense

$ 1,222.5

$ 941.1

Interest Coverage

5.00 x

7.74 x

Conference

Call Information and Other Selected Data

JBS

will host a conference call to discuss its financial results on Tuesday, August 11, 2026, at 9:00 a.m. Eastern Time. The live webcast

will be available on the JBS Investor Relations website at https://ir.jbsglobal.com/, where a replay of the webcast, the accompanying

presentation, the earnings release, financial statements, and other supplemental information will also be available following the event.

The webcast can also be accessed directly by clicking here. To add the event to your calendar, click here.

This

press release is being made in respect of JBS N.V. and its subsidiaries (collectively, the “JBS Group”).

Forward-Looking

Statements

make statements about future events that are subject to risks and uncertainties. Such statements are based on the beliefs and assumptions

of our Management and information to which the Company currently has access. Statements about future events include information about

our current intentions, beliefs or expectations, as well as those of the members of the Company’s Board of Directors and Officers.

Forward-looking

statements may include information on possible or presumed operating results, as well as statements that are preceded, followed or that

include the words “believe,” “may,” “will,” “continue,” “expects,” “predicts,”

“intends,” “plans,” “estimates,” or similar expressions.

Forward-looking

statements and information are not guarantees of performance. They involve risks, uncertainties and assumptions because they refer to

future events, depending, therefore, on circumstances that may or may not occur. Future results and shareholder value creation may differ

materially from those expressed or implied by the forward-looking statements. Many of the factors that will determine these results and

values are beyond our ability to control or predict.

IFRS

and Non-GAAP Financial Measures

This

release is prepared under IFRS and also includes certain non-GAAP financial measures. These measures are not calculated in accordance

with any generally accepted accounting principles (GAAP) or International Financial Reporting Standards (IFRS) and should not be viewed

as substitutes for IFRS metrics such as net income, operating cash flow, or other measures of operating performance or liquidity.

present non-GAAP financial measures to provide additional information that we believe is useful and meaningful to investors. However,

such measures do not have standardized definitions and may therefore not be comparable to similarly titled measures presented by other

companies. Non-GAAP financial measures should always be considered together with, and not as alternatives to, the financial results reported

in accordance with IFRS as issued by the International Accounting Standards Board.

Additionally,

all the numbers are unaudited in the condensed consolidated interim financial information, the consolidated US GAAP figure includes non-audited

accounting GAAP adjustments in Seara and JBS Brazil, in addition to the Business Units that already report under US GAAP.

Investor

Contact: ir@jbsglobal.com

Guilherme

Cavalcanti (Global CFO)

Christiane

Assis (IRO)

Pedro

Bueno

Felipe

Brindo

Vítor

Figueira

Amanda

Harumi

EX-99.2 — PRESS RELEASE ISSUED BY JBS N.V. ON AUGUST 10, 2026

EX-99.2

Filename: ea030137401ex99-2.htm · Sequence: 3

Exhibit 99.2

Tomazoni to Become JBS Vice Chairman

Wesley Batista Filho to Become JBS Global CEO

Amstelveen, Netherlands – August 10, 2026 – JBS

N.V. announced today that Wesley Batista Filho will become Global CEO of the Company, effective January 2027. The appointment is part

of a planned leadership transition and reflects the Company’s commitment to thoughtful succession planning. Batista Filho began his career

at JBS 15 years ago and has held leadership roles across the Company’s global operations, including as CEO of JBS Brazil, President of

Seara and, since 2023, CEO of JBS USA.

Gilberto Tomazoni will step down after 14 distinguished years with

the Company, including eight years as Global CEO. Having led JBS through one of the most transformative periods in its history, Tomazoni

will oversee the leadership transition over the next five months before assuming the role of Vice Chairman of the Board and Senior Advisor.

He will also continue to serve as Chairman of the Board of Pilgrim’s Pride Corporation (PPC) and will become Chairman of the J&F

Institute, an institution dedicated to developing the next generation of business leaders.

During Tomazoni’s tenure, JBS evolved into a more diversified, resilient

and global food company. Revenue grew 73%, from US$49.7 billion to US$86.2 billion, the Company expanded into new protein categories,

strengthened its portfolio of branded and value-added products, invested in biotechnology, achieved investment-grade status and successfully

completed its listing on the New York Stock Exchange, positioning JBS for its next phase of growth.

“I’m honored to take on this responsibility and build on the extraordinary

work accomplished by Tomazoni during his tenure as CEO. Having worked alongside him for more than a decade, Tomazoni and I have built

a great working relationship and a shared vision – grounded in the Company’s values. Our priorities remain clear: supporting

our team members, serving our customers and producer partners, operating with excellence and creating long-term value for our shareholders.

I look forward to working with our teams around the world as we continue building an even stronger JBS”, said Wesley Batista Filho.

“Wesley has a track record of success at JBS and knows our business

deeply. He started at the ground level of operations, going on to lead JBS Brazil and Seara to excellent results. Over the past three

years, he has led JBS in the United States, where we generate more than half of our revenue, building a stronger, more competitive business

and delivering important strategic advances across our operations. I’m confident he is the right leader to guide JBS through its next

chapter. He understands our business, our culture and our people, and I believe he will continue building on our strong foundation while

leading the Company to new opportunities for growth and value creation”, said Gilberto Tomazoni.

“It has been an honor to lead this great company over the past

eight years. JBS is stronger, more diversified and better positioned for the future than at any point in its history. With a strong leadership

team, a clear strategy and exceptional businesses around the world, I believe this is the right time for the Company to begin its next

chapter under Wesley’s leadership. I am deeply grateful to our team members, customers, producer partners and shareholders for their trust

and support throughout this journey. I wish Wesley every success”, Tomazoni added.

About Wesley Batista Filho

Wesley Batista Filho currently serves as JBS USA CEO, overseeing the

company’s North American business since 2023. He began his career at JBS in 2011 as a trainee at the Greeley, Colo., beef facility

before moving to São Paulo to work in the beef export division. From 2012 to 2013, he led the company’s beef operations in

Uruguay and Paraguay. He then moved to Calgary, Alberta, where he served as President of JBS Canada from 2014 to 2015, before returning

to Greeley to lead JBS USA Fed Beef, the company’s largest global business unit, from 2016 to 2017.

Wesley returned to São Paulo in 2017 to serve as CEO of JBS

Brazil. In 2020, he became CEO of Seara, the company’s value-added, poultry and pork business in Brazil, in addition to his responsibilities

as JBS Brazil CEO. In 2022, he assumed the role of Global President of Operations, overseeing the company’s global operational footprint,

including in North America, South America, Oceania and Europe.

In 2023, Wesley returned to Greeley for a third time and was appointed

CEO of JBS USA, the company’s largest global platform in terms of revenue. JBS USA is a leading American food company with more

than 60 beef, pork, poultry, prepared foods and other food production facilities and 70,000 team members in 31 states.

About Gilberto Tomazoni

Gilberto Tomazoni spent 27 years at Sadia, where he began his career

as an intern and later became CEO. He then spent three years at Bunge Alimentos as Vice President, leading the Food and Ingredients business,

and also served as Executive Director for South and Central America. Tomazoni joined JBS in 2013 as Global President of the Poultry Business

and later became President of Seara. In 2015, he was appointed Global President of Operations, in 2017 became Global COO, and in December

2018 was named Global CEO. He currently serves as a member of the Board of Directors of JBS N.V. He has also served as Chairman of the

Board of Pilgrim’s Pride Corporation for 13 years.

About JBS

JBS is a leading global food company with a diversified portfolio of

high-quality products, including poultry, pork, beef, lamb, fish and plant-based proteins. The company employs more than 282,000 people

and operates in over 20 countries, including Brazil, the United States, Canada, the United Kingdom and Australia. Worldwide, JBS offers

a broad portfolio of brands recognized for their excellence and innovation, including Friboi, Seara, Swift, Pilgrim’s Pride, Moy

Park, Primo and Just Bare, among others, reaching consumers in 180 countries every day. The company also invests in related businesses,

including leather, biodiesel, collagen, fertilizers, natural casings, solid waste management solutions, recycling and transportation,

with a focus on the circular economy. Learn more at jbsglobal.com.

Contacts:

Nikki Richardson

Nikki.Richardson@jbssa.com

GRAPHIC

Filename: ea030137401_ex99-1img1.jpg · Sequence: 4

Binary file (12136 bytes)

Download ea030137401_ex99-1img1.jpg

GRAPHIC

Filename: ea030137401_ex99-1img2.jpg · Sequence: 5

Binary file (46198 bytes)

Download ea030137401_ex99-1img2.jpg

GRAPHIC

Filename: ea030137401_ex99-1img3.jpg · Sequence: 6

Binary file (89860 bytes)

Download ea030137401_ex99-1img3.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 11

v3.26.1

Cover

Aug. 10, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Aug. 10, 2026

Entity File Number

001-42678

Entity Registrant Name

JBS

N.V.

Entity Central Index Key

0001791942

Entity Tax Identification Number

98-1861274

Entity Incorporation, State or Country Code

Entity Address, Address Line One

Stroombaan 16, 5th Floor

Entity Address, City or Town

Amstelveen

Entity Address, Country

Entity Address, Postal Zip Code

1181

City Area Code

Local Phone Number

20 656 47 00

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Class A common shares, par value €0.01 per share

Trading Symbol

JBS

Security Exchange Name

NYSE

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

ISO 3166-1 alpha-2 country code.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCountry

Namespace Prefix:

dei_

Data Type:

dei:countryCodeItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration